Prothena Corp. (PRTA) Misses Q4 EPS by 29c

Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($1.41), $0.29 worse than the analyst estimate of ($1.12). Revenue for the quarter came in at $170 thousand versus the consensus estimate of $5.35 million.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c